Your browser doesn't support javascript.
loading
Role of Fisetin in Selected Malignant Neoplasms in Women.
Markowska, Anna; Antoszczak, Michal; Kacprzak, Karol; Markowska, Janina; Huczynski, Adam.
Afiliação
  • Markowska A; Department of Perinatology and Women's Health, Poznan University of Medical Sciences, 60-535 Poznan, Poland.
  • Antoszczak M; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, 61-614 Poznan, Poland.
  • Kacprzak K; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, 61-614 Poznan, Poland.
  • Markowska J; Gynecological Oncology Center, Poznanska 58A, 60-850 Poznan, Poland.
  • Huczynski A; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, 61-614 Poznan, Poland.
Nutrients ; 15(21)2023 Nov 05.
Article em En | MEDLINE | ID: mdl-37960338
ABSTRACT
A promising therapeutic window and cost-effectiveness are just two of the potential advantages of using naturally derived drugs. Fisetin (3,3',4',7-tetrahydroxyflavone) is a natural flavonoid of the flavonol group, commonly found in fruit and vegetables. In recent years, fisetin has gained wide attention across the scientific community because of its broad spectrum of pharmacological properties, including cytotoxic activity against most abundant cancers. By stimulating or inhibiting selected molecular targets or biochemical processes, fisetin could affect the reduction of metastasis or cancer progression, which indicates its chemotherapeutic or chemopreventive role. In this review, we have summarized the results of studies on the anticancer effects of fisetin on selected female malignancies, both in in vitro and in vivo tests, i.e., breast, cervical, and ovarian cancer, published over the past two decades. Until now, no article dedicated exclusively to the action of fisetin on female malignancies has appeared. This review also describes a growing number of nanodelivery systems designed to improve the bioavailability and solubility of this natural compound. The reported low toxicity and activity of fisetin on cancer cells indicate its valuable potential, but large-scale clinical trials are urgently needed to assess real chemotherapeutic efficacy of this flavonoid.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article